Solon Eiendom ASA (BNRPF) Stock Price, News & Analysis

Company Overview

Solon Eiendom ASA acquires, develops, and sells residential real estate properties in Norway. The company was formerly known as Bionor Pharma ASA and changed its name to Solon Eiendom ASA. The company was founded in 2006 and is based in Oslo, Norway. Solon Eiendom ASA is a subsidiary of Samhällsbyggnadsbolaget i Norden AB (publ). As on January 20, 2022, Solon Eiendom ASA was taken private.

Key Stats

• Today's Range: $2.40 to $2.40
• 50-Day Range: $2.40 to $2.40
• 52-Week Range: $2.40 to $2.40
• Volume: N/A
• Average Volume: 100 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BNRPF Stock Analysis - Frequently Asked Questions

How have BNRPF shares performed this year?

Solon Eiendom ASA's stock was trading at $2.40 at the start of the year. Since then, BNRPF stock has increased by 0.0% and is now trading at $2.40.
View the best growth stocks for 2025 here.

How do I buy shares of Solon Eiendom ASA?

Shares of BNRPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Real Estate
• Industry: Real Estate - Development
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:BNRPF
• CIK: N/A
• Web: www.soloneiendom.no
• Phone: 47 22 29 66 90
• Fax: N/A
• Employees: 49
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A